Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 8 590 KRW -2.94% Market Closed
Market Cap: ₩112.3B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-62%
5Y
-179%
10Y
-
Investing Cash Flow
+
3Y
-
5Y
-19%
10Y
-
Financing Cash Flow
+
3Y
-25%
5Y
-34%
10Y
-

Cash Flow Statement
CJ Bioscience Inc

Rotate your device to view
Cash Flow Statement
Currency: KRW
Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(3 767)
(4 346)
(4 988)
(7 616)
(7 808)
(8 763)
(10 420)
(14 528)
(14 928)
(19 272)
(21 962)
(23 075)
(29 228)
(34 913)
(36 031)
(37 754)
(36 744)
(22 913)
(23 010)
(21 166)
(21 616)
(32 838)
(31 592)
(30 746)
(28 314)
Depreciation & Amortization
633
731
786
1 034
916
1 051
1 143
1 272
1 362
1 562
2 132
2 842
3 409
3 900
4 285
4 525
4 935
5 146
4 998
4 754
4 494
4 321
4 246
4 165
4 079
Stock-Based Compensation
708
677
650
578
183
134
(122)
133
395
556
713
693
678
544
508
0
0
142
0
0
0
0
0
0
0
Other Non-Cash Items
713
800
712
779
576
837
2 219
6 650
7 343
10 278
9 776
6 653
6 589
3 138
2 242
1 127
461
(8 002)
(8 348)
(8 703)
(8 822)
144
123
504
458
Cash Taxes Paid
(3)
(11)
1
(10)
13
32
20
(15)
18
5
32
56
86
142
185
47
14
1
17
46
84
71
21
31
(13)
Cash Interest Paid
0
0
0
90
172
249
325
315
309
361
0
206
138
30
65
108
153
191
224
257
289
312
330
344
352
Change in Working Capital
305
308
(65)
(220)
(2 794)
(1 104)
(1 503)
(1 540)
1 229
(1 005)
(204)
1 358
3 534
6 883
3 021
5 708
3 800
870
2 964
(34)
(361)
613
(1 992)
(1 208)
(1 678)
Cash from Operating Activities
(2 116)
N/A
(2 506)
-18%
(3 555)
-42%
(6 024)
-69%
(9 111)
-51%
(7 979)
+12%
(8 561)
-7%
(8 147)
+5%
(4 994)
+39%
(8 437)
-69%
(10 257)
-22%
(12 222)
-19%
(15 695)
-28%
(20 993)
-34%
(26 482)
-26%
(26 394)
+0%
(27 549)
-4%
(24 899)
+10%
(23 395)
+6%
(25 149)
-7%
(26 305)
-5%
(27 760)
-6%
(29 215)
-5%
(27 286)
+7%
(25 454)
+7%
Investing Cash Flow
Capital Expenditures
(354)
(453)
(24 066)
(24 145)
(23 922)
(18 866)
4 722
4 569
4 116
(979)
(2 516)
(3 382)
(3 261)
(4 870)
(3 463)
(15 827)
(15 803)
(16 417)
(16 217)
(2 765)
(2 749)
(584)
(599)
(601)
(272)
Other Items
(3 197)
(25 712)
(8 149)
(1 318)
(20 367)
(7 640)
(13 522)
(17 079)
6 169
7 431
4 262
989
11 022
12 035
0
0
0
33 116
0
33 116
33 142
(66 974)
(61 471)
(47 581)
(52 551)
Cash from Investing Activities
(3 551)
N/A
(26 165)
-637%
(32 215)
-23%
(25 463)
+21%
(44 289)
-74%
(26 507)
+40%
(8 800)
+67%
(12 510)
-42%
10 285
N/A
6 453
-37%
1 747
-73%
(2 393)
N/A
7 761
N/A
7 165
-8%
6 741
-6%
(5 623)
N/A
(15 631)
-178%
16 699
N/A
16 899
+1%
30 351
+80%
30 393
+0%
(67 557)
N/A
(62 070)
+8%
(48 182)
+22%
(52 823)
-10%
Financing Cash Flow
Net Issuance of Common Stock
6 848
23 614
23 743
24 232
17 593
827
872
383
175
73 479
73 354
73 354
73 354
50
0
0
44 978
44 977
0
0
0
39 970
0
0
0
Net Issuance of Debt
(255)
(345)
11 601
11 500
41 540
41 519
29 578
29 550
(400)
(22 768)
(22 956)
(22 463)
(21 385)
1 222
1 015
708
(21 698)
(21 772)
(21 529)
(21 516)
(279)
(159)
(296)
(613)
(742)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
(250)
(200)
(279)
(331)
(261)
(379)
(377)
(409)
(312)
(330)
(344)
(352)
Cash from Financing Activities
6 587
N/A
23 269
+253%
35 345
+52%
35 732
+1%
59 133
+65%
42 346
-28%
30 450
-28%
29 933
-2%
(226)
N/A
50 711
N/A
50 398
-1%
50 891
+1%
51 969
+2%
1 022
-98%
815
-20%
429
-47%
22 949
+5 245%
22 944
0%
23 069
+1%
23 083
+0%
(689)
N/A
39 499
N/A
39 344
0%
39 013
-1%
38 875
0%
Change in Cash
Effect of Foreign Exchange Rates
41
9
35
59
48
41
49
10
38
78
59
61
(86)
70
67
90
130
27
21
21
77
32
11
(10)
(5)
Net Change in Cash
961
N/A
(5 394)
N/A
(389)
+93%
4 303
N/A
5 781
+34%
7 901
+37%
13 137
+66%
9 286
-29%
5 102
-45%
48 805
+857%
41 946
-14%
36 338
-13%
43 948
+21%
(12 737)
N/A
(18 859)
-48%
(31 497)
-67%
(20 101)
+36%
14 772
N/A
16 593
+12%
28 306
+71%
3 477
-88%
(55 786)
N/A
(51 930)
+7%
(36 465)
+30%
(39 407)
-8%
Free Cash Flow
Free Cash Flow
(2 470)
N/A
(2 959)
-20%
(27 621)
-833%
(30 169)
-9%
(33 032)
-9%
(26 845)
+19%
(3 839)
+86%
(3 579)
+7%
(879)
+75%
(9 416)
-971%
(12 773)
-36%
(15 604)
-22%
(18 957)
-21%
(25 863)
-36%
(29 945)
-16%
(42 221)
-41%
(43 352)
-3%
(41 315)
+5%
(39 612)
+4%
(27 914)
+30%
(29 053)
-4%
(28 344)
+2%
(29 813)
-5%
(27 887)
+6%
(25 727)
+8%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.